Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. ukraine
  4. tumor specificity
Show results for
Products
Services
Software
Applications

Companies


Refine by
Locations
Back to All Locations

  • Europe
  • Ukraine
Business Types

  • Manufacturer
  • Technology
  • Software vendor
  • Service provider
  • Custom manufacturer
Industries served

  • Medical / Health Care
  • Monitoring and Testing
  • Chemical & Pharmaceuticals
  • Agriculture
  • Environmental
  • Health and Safety
  • University / Academia / Research
  • Manufacturing, Other
  • Energy
Employees

  • 101-1000
  • Over 1000

Tumor Specificity Suppliers Serving Ukraine

41 companies found
Serving UkraineNear Ukraine

NeraCare GmbH

NeraCare GmbH

based inFrankfurt, GERMANY
NeraCare develops and commercializes molecular diagnostic tests for patients with skin cancer. The tests provide actionable, tumor-specific information for each individual patient. The information is used to make improved treatment decisions, i.e. ...
CONTACT SUPPLIER

MDxHealth

MDxHealth

based inIrvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
MdxHealth - Methylation-Specific PCR Technology (MSP)

MdxHealth - Methylation-Specific PCR Technology (MSP)

MDxHealth’s technology platform is called methylation-specific PCR (MSP), which is a proprietary DNA-based technology that functions on standard commercial PCR equipment. MSP is extremely powerful and accurate with the ability to detect a ...
CONTACT SUPPLIER

Nuclidium AG

Nuclidium AG

based inBasel, SWITZERLAND
Nuclidium AG specializes in leveraging the unique properties of copper radionuclides in conjunction with tumor-specific molecules to enhance the precision, performance, and accessibility of targeted radiotherapy and diagnostics. Their proprietary ...
Nuclidium CuTrace - Platform for Targeted Radiotherapy and Diagnostics

Nuclidium CuTrace - Platform for Targeted Radiotherapy and Diagnostics

Nuclidium AG leverages the unique properties of copper radionuclides to advance precision radiotherapy and diagnostics. Their proprietary CuTrace™ platform combines copper nuclides with tumor-specific ...
CONTACT SUPPLIER

Hookipa Pharma Inc.

Hookipa Pharma Inc.

based inVienna, AUSTRIA
Hookipa Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. We are using our non-replicating and ...
Immune System of Arenavirus Platform

Immune System of Arenavirus Platform

The immune system is the body’s natural defense mechanism against pathogens. Our proprietary technology is capable of targeting and treating disease with a tailored immune response. Our science is based on a novel and highly differentiated ...
CONTACT SUPPLIER

Eutilex Co.,Ltd.

Eutilex Co.,Ltd.

based inSeoul, SOUTH KOREA
Eutilex is Developing anti-tumor T cell therapy and antibody therapeutics based on its own proprietary immunotherapy technology We set a goal to be a leading company in anti-tumor immunotherapy markets through the technical innovation & early ...
Eutilex - Model EU501 (HER2 x 4-1BB) - 4-1BB mAb-based, Tumor Antigen

Eutilex - Model EU501 (HER2 x 4-1BB) - 4-1BB mAb-based, Tumor Antigen

4-1BB mAb-based, tumor antigen targeting bispecific ...
CONTACT SUPPLIER

Myeloid Therapeutics

Myeloid Therapeutics

based inCambridge, MASSACHUSETTS (USA)
Myeloid Therapeutics is a leader in the development of mRNA-based immunotherapies, focusing on harnessing and enhancing the natural capabilities of myeloid cells to combat cancer. The company's cutting-edge in vivo engineering platform is designed ...
mRNA Cell Therapy Technology

mRNA Cell Therapy Technology

Myeloid is focused on advancing its ATAK CAR monocytes, which are myeloid cells with innate immune receptor-inspired CARs to recognize and kill cancer. Additionally, Myeloid has streamlined manufacturing for its ATAK cell therapy candidates through ...
CONTACT SUPPLIER

T-Knife GmbH

T-Knife GmbH

based inBerlin, GERMANY
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer. The company is initially focused on T cell receptor (TCR) engineered T cell therapies (TCR-Ts), a promising modality that holds the ...
CONTACT SUPPLIER

LAVA Therapeutics N.V.

LAVA Therapeutics N.V.

based inUtrecht, NETHERLANDS
At LAVA, we are focused on applying our expertise in gamma-delta T cell engagers. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor ...
CONTACT SUPPLIER

Elicio Therapeutics

Elicio Therapeutics

based inBoston, MASSACHUSETTS (USA)
We harness the natural power of the lymph nodes to generate enhanced immune responses against tumors. Our science is defining the future of immunotherapy, with the goal of giving patients who are battling cancer their best possible outcome. We’re ...
Elicio - Model ELI-002 - mKRAS Cancer Vaccine

Elicio - Model ELI-002 - mKRAS Cancer Vaccine

Our lymph node-targeted mKRAS cancer vaccine; Our Amphiphile (AMP)-powered lead candidate, ELI-002, generates a robust immune response against mutant Kristen rat sarcoma (mKRAS), with the potential to offer patients a stronger fight against the most ...
CONTACT SUPPLIER

Treos Bio Limited

Treos Bio Limited

based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
Treos - Personal Antigen Selection Calculator Technologies (PASCal)

Treos - Personal Antigen Selection Calculator Technologies (PASCal)

At TREOS we use knowledgebase and algorithm embedded in PASCal (Personal Antigen Selection Calculator) tool to develop personal cancer immunotherapies. PASCal supports the development of immunotherapies for single individuals and a population of ...
CONTACT SUPPLIER

OnLume Inc.

OnLume Inc.

based inMadison, WISCONSIN (USA)
OnLume Surgical is a Madison, WI based medical device company that develops innovative imaging technology designed to advance surgical precision, optimize patient outcomes and reduce morbidity and costs. We have developed a new standard in ...
OnLume - Surgical Imaging System

OnLume - Surgical Imaging System

The OnLume Imaging System Illuminates Critical Anatomy in Real-Time During Surgery to Optimize Precision. The fluorescence image quality generated by the OnLume Imaging System is grounded by a robust and growing body of science that has informed ...
CONTACT SUPPLIER

ProImmune Ltd.

ProImmune Ltd.

based inOxford, UNITED KINGDOM
ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses. We offer unique solutions for preclinical and clinical immunology research, including a comprehensive and integrated antigen ...
CONTACT SUPPLIER

Metaclipse Therapeutics Corporation

Metaclipse Therapeutics Corporation

based inAtlanta, GEORGIA (US) (USA)
Metaclipse Therapeutics Corporation is developing novel personalized vaccine immunotherapies for cancer. MembrexTM, a proprietary platform approach tailored to each patient and their specific tumor, consists of ‘membrane vesicles’ prepared from a ...
Metaclipse Membrex - Novel Personalized Vaccine Immunotherapies for Cancer

Metaclipse Membrex - Novel Personalized Vaccine Immunotherapies for Cancer

Metaclipse Therapeutics Corporation is developing novel personalized vaccine immunotherapies for cancer. MembrexTM, a proprietary platform approach tailored to each patient and their specific tumor, consists of ...
CONTACT SUPPLIER

Invivoscribe, Inc.

Invivoscribe, Inc.

based inSan Diego, CALIFORNIA (USA)
Invivoscribe is a global leader in molecular diagnostics, providing a comprehensive range of standardized, CE-marked in vitro diagnostic products and companion diagnostics for hematology-oncology. The company's offerings include research use only ...
CONTACT SUPPLIER

Onegene Biotechnology

Onegene Biotechnology

based inSuwon, SOUTH KOREA
Onegene Biotechnology develops transformative therapeutics for the chronic and complex diseases. Our UniStac platform allows rationale-based design of multispecific drug in true plug-and-play ...
Model OGB23501 - Tri-Specific Tumor Microenvironment (TME)

Model OGB23501 - Tri-Specific Tumor Microenvironment (TME)

OGB23501 is a first-in-class tri-specific tumor microenvironment (TME) immune activator, which simultaneously targets PD-1, CTLA-4, and VEGF. We aim to develop it as a potential backbone therapy for melanoma, NSCLC, ...
CONTACT SUPPLIER

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics Ltd.

based inAbingdon, UNITED KINGDOM
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...
PsiOxus - Model T-SIGn - Viral Vector Platform Technology

PsiOxus - Model T-SIGn - Viral Vector Platform Technology

Our clinically validated T-SIGn® viral vector platform delivers multiple transgene payloads that re-program the tumor microenvironment of both primary and metastatic tumors. Our platform can integrate rationally designed synthetic agents to ...
CONTACT SUPPLIER

SurgiMab

SurgiMab

based inMontpellier, FRANCE
SurgiMAb develops injectable fluorescent conjugates to be used during Fluorescence-Guided Surgery (FGS) by oncology surgeons so they can clearly delineate tumors and visualize infra-clinical size nodules invisible to their naked eyes. SurgiMab was ...
SurgiMab - Intraoperative Detection Technology of Tumors

SurgiMab - Intraoperative Detection Technology of Tumors

SurgiMab’s tumor-targeting fluorescent molecules enable real time visualization of tumor margins, tumor spread and micro-tumors which are invisible to the naked eye. As ...
CONTACT SUPPLIER

Immatics N.V.

Immatics N.V.

based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
Immatics TCER - Bispecific T cell Engaging Receptors

Immatics TCER - Bispecific T cell Engaging Receptors

Bispecific T cell engaging receptors (TCER®) are off-the-shelf biologics that leverage the body’s immune system by redirecting and activating T cells towards cancer cells expressing specific tumor targets. ...
CONTACT SUPPLIER

T3 Pharmaceuticals AG

T3 Pharmaceuticals AG

based inBasel, SWITZERLAND
T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of ...
Proprietary Platform for Protein Delivery

Proprietary Platform for Protein Delivery

T3 Pharma has developed a proprietary cancer therapy platform based on regulating and harnessing the natural behaviours of live bacteria. The genetically engineered bacteria selectively target solid tumors, where they deliver chosen protein payloads ...
CONTACT SUPPLIER

Natera, Inc.

Natera, Inc.

based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Model Signatera - Transforming the Management of Cancer with Personalized Testing

Model Signatera - Transforming the Management of Cancer with Personalized Testing

Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT